News
News
Pharma Pulse
Multimedia
Editorial Podcasts
Editorial Videos
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
Publications
Pharmaceutical Executive
Brand Insights
Resources
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
Spotlight
Pharmaceutical Executive APEX Awards
Latest Executive Roundtables
Topic
DE&I
Executive Profiles
Sales and Marketing
Strategy
Technology
News
News
Pharma Pulse
Multimedia
Editorial Podcasts
Editorial Videos
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
Publications
Pharmaceutical Executive
Brand Insights
Resources
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
Advertisement
Sales & Marketing
| DE&I
| Executive Profiles
| Executive Roundtable
| Finance
| Global
| Industry Trends
| Leadership
| Legal
| Market Access
| Opinion
| Pandemic
| Patient Engagement
| Pricing
| R&D/Clinical Trials
| Regulatory
| Strategy
| Supply Chain
| Sustainability
| Technology
View All >>
DE&I
Executive Profiles
Executive Roundtable
Finance
Global
Industry Trends
Leadership
Legal
Market Access
Opinion
Pandemic
Patient Engagement
Pricing
R&D/Clinical Trials
Regulatory
Sales & Marketing
Strategy
Supply Chain
Sustainability
Technology
SPOTLIGHT
-
Pharmaceutical Executive APEX Awards
| Latest Executive Roundtables
Justin Test, BI Contributor, Brand Strategy, Widget Company
home
/
authors
/
justin-test-bi-contributor-brand-strategy-widget-company
Born in California in 1979.
Articles
JB article test
Justin Test, BI Contributor, Brand Strategy, Widget Company
January 2nd 2020
test test test
Latest Updated Articles
Published: June 19th 2024
| Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: November 8th 2024
| Updated: November 12th 2024
Key Findings of the NIAGARA and HIMALAYA Trials
Published: November 8th 2024
| Updated: November 12th 2024
Johnson & Johnson Submits Regulatory Applications for Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
Published: October 31st 2024
| Updated: November 12th 2024
Expanded Access Treatment Options: Q&A with Johnson & Johnson Innovative Medicine’s Christine MacCracken
Published: October 2nd 2024
| Updated: November 12th 2024
Unlocking value and cost savings in patient services with technology and talent
Published: October 8th 2024
| Updated: November 12th 2024
Are You Up to Date With the Latest FDA Guidance?